Liebens Pharma SRL
Liebens Pharma reported total assets of €1.05m at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Jul 2026).
By total assets for 2025, Liebens Pharma ranks in the top half of the 24,102 companies in its sector (NACE 6421) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Liebens Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +67 % Total assets +6 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Liebens Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 134,538 € | ||||
| Equity | 219,610 € | ||||
| Cash | 72,065 € | ||||
| EBITDA | 193,227 € | ||||
| Total assets | €1.05m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 02 Jun 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 07 Jun 2022
Liebens Pharma's financial analysis
- Solvency21.0%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Liebens Pharma
Liebens Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0637.716.996
- VAT number
- BE0637716996
- Peppol
- Registered · 0208:0637716996 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 Sep 2015
- Registered office
- 3670 Oudsbergen
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Activities of holding companies (NACE 64210)
Liebens Pharma (SRL) has been based in Oudsbergen since 2015, active in: activities of holding companies. For 2025, it reports a net profit of 134,538 € and equity of 219,610 €; its revenue is not published. Its solvency stands at 21.0%, below the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Liebens Pharma
Companies in the same business, of comparable size and area, outside its group.
- Upsilon Activities of holding companies Hasselt · balance sheet €1.05m
- Brocap Investments Activities of holding companies Oudenaarde · balance sheet €1.04m
- Eiffel Management Activities of holding companies Aubel · balance sheet €1.04m
- Holding DataStories Activities of holding companies Bonheiden · balance sheet €1.04m
- Squeeze IT Activities of holding companies Hove · balance sheet €1.04m
- De Bleser Services Activities of holding companies Rotselaar · balance sheet €1.04m
- Kuman 1920 Activities of holding companies Grobbendonk · balance sheet €1.04m
- Krana Activities of holding companies Kontich · balance sheet €1.03m
Frequently asked questions about Liebens Pharma
What is the revenue of Liebens Pharma?
Liebens Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Liebens Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0637716996 for Liebens Pharma, if the company is VAT-registered. Its company number (CBE) is 0637.716.996.
Where is the registered office of Liebens Pharma?
According to the CBE register, the registered office of Liebens Pharma is in 3670 Oudsbergen.
What is the equity of Liebens Pharma?
At the close of the 2025 financial year, the equity of Liebens Pharma amounts to 219,610 €, a solvency of 21.0% of total assets.
Who manages Liebens Pharma?
The register lists 1 active mandates at Liebens Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Liebens Pharma within its sector?
By total assets for 2025, Liebens Pharma ranks in the top half of the 24,102 companies in its sector (NACE 6421) in Belgium that filed accounts for that financial year.
The full file of Liebens Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →